mobile header
Dr Anjali Meena

Dr Anjali Meena american Oncology Hospitals

Dr Anjali Meena

Nuclear Medicine

Book an Appointment
Share Profile share

Dr Anjali Meena is one of the top Nuclear Medicine specialists in India. Currently, Dr Anjali Meena is serving as a Consultant in Nuclear Medicine at American Oncology Institute, Sri Ganganagar, specializing in advanced molecular imaging and radionuclide therapies. With over 3 years of experience in Nuclear Medicine, Dr Meena has developed proficiency in PET/CT, SPECT/CT, and gamma camera imaging for the diagnosis and management of a wide spectrum of conditions, including oncology, endocrinology, cardiology, orthopedics, and neurology. She is skilled in therapeutic nuclear medicine, offering treatments such as for thyroid disorders, prostate and neuroendocrine cancers.

She completed her MBBS from Rabindranath Tagore Medical College (R.N.T. MC), Udaipur, and went on to pursue MD in Nuclear Medicine from the prestigious All India Institute of Medical Sciences (AIIMS), Rishikesh. She further enhanced her expertise by serving as a Senior Resident at PGIMER, Chandigarh, where she gained significant clinical experience in complex nuclear medicine procedures. Dr Meena is also a keen researcher with multiple national and international publications to her credit. She has presented scientific work at reputed conferences including SNMICON, BIR, and EANM, and continues to contribute to evidence-based advancements in Nuclear Medicine. Her clinical approach combines cutting-edge diagnostic techniques with compassionate patient care, ensuring accurate disease evaluation and improved treatment outcomes.

  • MBBS — Rabindranath Tagore Medical College (R.N.T. MC), Udaipur (2019)
  • MD, Nuclear Medicine — All India Institute of Medical Sciences (AIIMS), Rishikesh (2022)
  • Diagnostic PET-CT Imaging
  • PET-CT guided biopsies
  • PET-CT guided steroid and antibiotic injections
  • Radionuclide therapies & Radio synovectomy
  • Nuclear Cardiology: Stress/Rest, Myocardial perfusion, Viability, PYP Imaging & MUGA
  • Gamma Camera Imaging: Brain, Renal, Thyroid, Parathyroid, GIT, Hepato-biliary, V/Q Scan, Salivary, Hepato-splenic scintigraphy, Lymphoscintigraphy, Meckel's Scan
  • Current status of bone single-photon emission computed tomography combined with computed tomography in evaluation of feet and ankle pain. J RadiatMed Trop 2022;3:17
  • Unexpected Metastasis to Breast, Lymph Node, Subcutaneous, Abdominal Wall, Intraabdominal, and Bone is Osteogenic Osteosarcoma: An Unusual Presentation on Bone Scintigraphy. Indian J Nucl Med. 2022 Jan-Mar;37(1):91-93.
  • Role of 99m Tc-Methylene Diphosphonate Bone Scintigraphy in the Evaluation of the Viability and the incorporation of the Bone Allograft Used in Orthopedic Reconstruction. Indian J Nucl Med. 2022 Jan-Mar;37(1):74-77.
  • A Case of extracranial metastasis of Glioblastoma Multiforme seen on Bone Scintigraphy. Mol Imaging Radionucl Ther MIRT-09815.
  • Tibial Stress Fracture and "Shin Splint" Syndrome in the Same Patient Diagnosed on 99mTC-Methylene Diphosphonate Bone Scintigraphy and Single-Photon Emission/Computed Tomography. Indian J Nucl Med. Jan-Mar; 38(1):76-78.
  • Tubarial salivary glands on PSMA ligands based PET imaging and post 177Lu PSMA therapy scan: reiterating its importance. Asia Oceania Journal of Nuclear Medicine and Biology (2024) 12(1) 43-45.
  • Overview of imaging Modalities in Evaluation of Bone Allograft Viability. Journal Of Radiation and Nuclear Medicine. 10.14302/issn.2766-8630.jrnm203689.
  • E-POSTER presentation at 57th annual conference of the society of Nuclear Medicine. (SNMICON 2020 Virtual).
  • E-POSTER presentation at British Institute of Radiology (BIR) annual conference 2021.
  • Comparative Analysis of PRIMARY Score, PSMA Expression Score and SUV based measurements for detection of clinically significant prostate cancer: A Single-centre retrospective study. under submission process 2025.
  • Detection of Docetaxel-induced interstitial Pneumonitis on Ga-68 PSMA PET/CT imaging. Indian Journal of Nuclear Medicine 39(3):p 220-221, May-Jun 2024. DOI:10.4103/ijnm.ijnm_147_23.
  • Post-Transplant Lymphoproliferative Disorder masquerading as Carcinoma Anorectum on F-18 FDG PET/CT under submission process 2025.
  • E-POSTER presentation at EANM 2024, Hamburg, Germany.
  • Rare Presentation of Mandibular Metastasis from Differentiated Thyroid Carcinoma: A Case Series-Experience from a Single Tertiary Care Hospital. Accepted on August 20th, 2025 in IJNM.
  • RMC Registration No- 42512

Recommended Doctors